In last trading session, Ocugen Inc (NASDAQ:OCGN) saw 4.13 million shares changing hands with its beta currently measuring 3.86. Company’s recent per share price level of $0.70 trading at -$0.03 or -4.55% at ring of the bell on the day assigns it a market valuation of $202.44M. That closing price of OCGN’s stock is at a discount of -201.43% from its 52-week high price of $2.11 and is indicating a premium of 8.57% from its 52-week low price of $0.64.
For Ocugen Inc (OCGN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Ocugen Inc (NASDAQ:OCGN) trade information
Upright in the red during last session for losing -4.55%, in the last five days OCGN remained trading in the green while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $0.70 price level, adding 7.88% to its value on the day. Ocugen Inc’s shares saw a change of -13.57% in year-to-date performance and have moved 3.53% in past 5-day. Ocugen Inc (NASDAQ:OCGN) showed a performance of -2.00% in past 30-days.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 86.0% to its current value. Analysts have been projecting 3.5 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -400.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -400.0% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 41.20% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 23.08% while estimates for its earnings growth in next 5 years are of 4.71%.
Ocugen Inc (NASDAQ:OCGN)’s Major holders
BLACKROCK INC. is the top institutional holder at OCGN for having 17.92 million shares of worth $27.78 million. And as of 2024-06-30, it was holding 6.9665 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 15.52 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.0339 of outstanding shares, having a total worth of $24.06 million.
On the other hand, Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 9.07 shares of worth $6.31 million or 3.11% of the total outstanding shares. The later fund manager was in possession of 8.7 shares on Nov 30, 2024 , making its stake of worth around $6.06 million in the company or a holder of 2.99% of company’s stock.
